Amgen Wins Patent Case On Enbrel® (etanercept)
Court Upholds Validity of Patent Claims Directed to Enbrel
Preliminary Injunction to Remain in Place
THOUSAND OAKS, Calif., Aug. 9, 2019, /PRNewswire/ -- Amgen (AMGN) today announced that the U.S. District Court for the District of New Jersey has ruled in Amgen's . . .
This content is for paid subscribers.
Impacting News August 9, 2019